Similar articles for PMID: 23950657

Year	Number of Results
1998	1
2000	1
2002	2
2003	4
2004	3
2005	3
2006	3
2007	3
2008	2
2009	5
2010	5
2011	7
2012	6
2013	11
2014	6
2015	4
2016	7
2017	1
2018	4
2019	2
2020	8
2021	3
2024	0

1

Potential role of gabapentin and extended-release gabapentin in the management of menopausal hot flashes.

Yadav M, Volkar J. Yadav M, et al. Int J Gen Med. 2013 Aug 7;6:657-64. doi: 10.2147/IJGM.S45880. eCollection 2013. Int J Gen Med. 2013. PMID: 23950657 Free PMC article.

2

Steady-state pharmacokinetics of gabapentin after administration of a novel gastroretentive extended-release formulation in postmenopausal women with vasomotor symptoms.

Cowles VE, Gordi T, Hou SY. Cowles VE, et al. Clin Drug Investig. 2012 Sep 1;32(9):593-601. doi: 10.1007/BF03261914. Clin Drug Investig. 2012. PMID: 22775354 Clinical Trial.

3

Phytoestrogens for menopausal vasomotor symptoms.

Lethaby A, Marjoribanks J, Kronenberg F, Roberts H, Eden J, Brown J. Lethaby A, et al. Cochrane Database Syst Rev. 2013 Dec 10;2013(12):CD001395. doi: 10.1002/14651858.CD001395.pub4. Cochrane Database Syst Rev. 2013. PMID: 24323914 Free PMC article. Review.

4

Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.

Utian WH. Utian WH. Health Qual Life Outcomes. 2005 Aug 5;3:47. doi: 10.1186/1477-7525-3-47. Health Qual Life Outcomes. 2005. PMID: 16083502 Free PMC article. Review.

5

Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors.

Tran S, Hickey M, Saunders C, Ramage L, Cohen PA. Tran S, et al. Support Care Cancer. 2021 Mar;29(3):1183-1193. doi: 10.1007/s00520-020-05754-w. Epub 2020 Sep 17. Support Care Cancer. 2021. PMID: 32940768 Review.

6

Menopausal hot flushes and night sweats: where are we now?

Archer DF, Sturdee DW, Baber R, de Villiers TJ, Pines A, Freedman RR, Gompel A, Hickey M, Hunter MS, Lobo RA, Lumsden MA, MacLennan AH, Maki P, Palacios S, Shah D, Villaseca P, Warren M. Archer DF, et al. Climacteric. 2011 Oct;14(5):515-28. doi: 10.3109/13697137.2011.608596. Epub 2011 Aug 18. Climacteric. 2011. PMID: 21848495 Review.

7

Assessment and treatment of hot flushes and menopausal mood disturbance.

Joffe H, Soares CN, Cohen LS. Joffe H, et al. Psychiatr Clin North Am. 2003 Sep;26(3):563-80. doi: 10.1016/s0193-953x(03)00045-5. Psychiatr Clin North Am. 2003. PMID: 14563098 Review.

8

Efficacy and safety of gabapentin and pregabalin in patients with vasomotor symptoms: a systematic review and meta-analysis.

Shan D, Zou L, Liu X, Shen Y, Cai Y, Zhang J. Shan D, et al. Am J Obstet Gynecol. 2020 Jun;222(6):564-579.e12. doi: 10.1016/j.ajog.2019.12.011. Epub 2019 Dec 20. Am J Obstet Gynecol. 2020. PMID: 31870736

9

Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women.

Glusman JE, Huster WJ, Paul S. Glusman JE, et al. Prim Care Update Ob Gyns. 1998 Jul 1;5(4):166. doi: 10.1016/s1068-607x(98)00066-3. Prim Care Update Ob Gyns. 1998. PMID: 10838311

10

Beyond frequency: who is most bothered by vasomotor symptoms?

Thurston RC, Bromberger JT, Joffe H, Avis NE, Hess R, Crandall CJ, Chang Y, Green R, Matthews KA. Thurston RC, et al. Menopause. 2008 Sep-Oct;15(5):841-7. doi: 10.1097/gme.0b013e318168f09b. Menopause. 2008. PMID: 18521049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

82 results

Results by year